Browse by CSHL Author

Stevens, Payton D, Sall, Emily, Zhong, Alex, Hostetter, Galen, Madaj, Zachary, Thalappillil, Jennifer, Dobin, Alexander, Park, Youngkyu, Tuveson, David A, Williams, Bart O (2022) FZD6 and RYK, non-canonical Wnt receptors in pancreatic cancer progression. In: Annual Meeting of the American-Association-for-Cancer-Research (AACR), APR 08-13, 2022, New Orleans, LA.

Caligiuri, Giuseppina, Thalappillil, Jennifer S, Shakiba, Mojdeh, Nadella, Sandeep, Hinds, Juliene, Courtois, Elise, Flynn, William F, Alagesan, Brinda, Yordanov, Georgi N, Kaminow, Benjamin, Robson, Paul, Perez-Mancera, Pedro A, Preall, Jonathan, Dobin, Alexander, Park, Youngku, Tuveson, David A (2022) Oncogenic KRAS signaling drives the activation of tissue-resident fibroblasts and is required to maintain CAF heterogeneity in pancreatic cancer. In: AACR Special Conference on Pancreatic Cancer, 2022 Sep 13-16, Boston, MA.

Thalappillil, Jennifer S, Caligiuri, Giuseppina, Nadella, Sandeep, Alagesan, Brinda, Yordanov, Georgi N, Shakiba, Mojdeh, Kaminow, Benjamin, Hinds, Juliene, Perez-Mancera, Pedro A, Preall, Jonathan, Dobin, Alexander, Park, Youngkyu, Tuveson, David A (2022) Oncogenic Kras drives cancer-associated fibroblast heterogeneity and substate changes in pancreatic cancer. In: American Association for Cancer Research Annual Meeting 2022, 2022 Apr 8-13, Philadelphia, PA.

Caligiuri, Giuseppina, Thalappillil, Jennifer, Hinds, Juliene, Courtois, Elise T, Flynn, William F, Robson, Paul, Dobin, Alexander, Park, Youngkyu, Tuveson, David A (2022) Spatial transcriptomics reveals heterogeneity and pathway dependencies of cancer associated fibroblasts in pancreatic ductal adenocarcinoma. In: Annual Meeting of the American-Association-for-Cancer-Research (AACR), APR 08-13, 2022, New Orleans, LA.

Cheng, Derek K, Oni, Tobiloba E, Thalappillil, Jennifer S, Park, Youngkyu, Ting, Hsiu-Chi, Alagesan, Brinda, Prasad, Nadia V, Addison, Kenneth, Rivera, Keith D, Pappin, Darryl J, Van Aelst, Linda, Tuveson, David A (May 2021) Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer. Proceedings of the National Academy of Sciences of USA, 118 (21). e2016904118-e2016904118. ISSN 0027-8424

Cheng, D. K., Oni, T. E., Park, Y., Thalappillil, J. S, Ting, H.-C., Alagesan, B., Prasad, N. V., Rivera, K. D., Pappin, D. J., Van Aelst, L., Tuveson, D. A. (September 2020) Oncogenic KRAS engages an RSK1/NF1 complex in pancreatic cancer. BioRxiv. (Unpublished)